Braze (BRZE) Is Up 5.3% After Raising 2026 Revenue Outlook Amid AI Adoption And Margin Pressures

• Braze, Inc. recently reported first-quarter 2026 results, with revenue rising to US$211 million from US$162.06 million a year earlier and its net loss narrowing to US$26.59 million, while also updating guidance and holding an annual meeting to vote on officer exculpation under Delaware law.
• Alongside strong uptake of its AI-powered tools and the appointment of Chris Lal as General Counsel to oversee legal and responsible-AI efforts, Braze raised both second-quarter and full-year revenue guidance, even as investors focused on pressure in profitability metrics and gross margins.
• Next, we’ll examine how Braze’s stronger revenue outlook but softer profitability guidance could influence its existing investment narrative around AI and scale.

The future of work is here. Discover the 35 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

Braze Investment Narrative Recap

To own Braze, you need to believe its AI‑heavy customer engagement platform can keep expanding with large enterprises while steadily improving unit economics from today’s loss‑making base. The key near term catalyst is whether AI products like BrazeAI and OfferFit can translate strong top‑line momentum into clearer progress on margins. The latest quarter, with higher revenue guidance but investor concern on profitability and gross margins, does not yet resolve that tension in a decisive way.

Among the recent developments, the appointment of Chris Lal as General Counsel stands out for investors watching data, AI and regulatory risk. His remit across privacy, intellectual property and responsible‑AI matters ties directly into Braze’s dependence on compliant, high‑performance data use and global data center expansion. How effectively Braze manages these legal and regulatory complexities could influence whether its AI‑driven growth story remains a catalyst or becomes a source of cost pressure.

Yet behind the strong AI narrative, investors still need to weigh growing regulatory and margin pressures that could...

Read the full narrative on Braze (it's free!)

Braze's narrative projects $1.2 billion revenue and $149.9 million earnings by 2029. This requires 18.0% yearly revenue growth and about a $281 million earnings increase from -$131.3 million today.

Uncover how Braze's forecasts yield a $34.85 fair value, a 36% upside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts were expecting about US$1.1 billion in revenue and much higher margins by 2028, so if you are weighing tighter privacy rules or weaker pricing power against this faster growth view, the latest AI‑driven results and guidance could shift how you see that trade off.

Explore 5 other fair value estimates on Braze - why the stock might be worth just $34.85!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Braze research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Braze research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Braze's overall financial health at a glance.

Interested In Other Possibilities?

Our top stock finds are flying under the radar-for now. Get in early:

• Outshine the giants: these 12 early-stage AI stocks could fund your retirement.
• We've uncovered the 10 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• AI is about to change healthcare. These 37 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com